Abstract
The response to the harm caused by risk factors related to atherosclerosis may consist of clinical-signs of cardiac and/or blood vessel ischemic pathology sometimes accompanied by arrhythmias and heart failure-, metabolic- signs of altered oxygen transport and pro-thrombotic changes of coagulation-fibrinolysis cascade-, and sympathetic features due to nerve stimulation, which cause changes in heart rate and blood pressure. Moreover, some special categories like women have the responses, which are influenced by their endocrine constellation. There is a different predisposition towards the markers of atherosclerosis in premenopausal woman, who displays atherogenic effects, and in women after the menopause who respond similarly to that of men. Finally, oxidative stress, which is a strong pro-thrombotic factor, increases the development of an atherosclerotic lesion.
From these data, there is no doubt that a large number of factors, primarily smoking and endothelial dysfunction influence the cardiovascular system causing a major incidence of cardiovascular events. In addition, there would be evidence that some factors related to atherosclerosis should be considered as an etiologic (causal) factor of cardiovascular alterations because they can lead, in the long run, to an irreversible damage to the heart and blood vessels.
Keywords: Smoking, endothelium, atherosclerotic markers.
Current Pharmaceutical Design
Title:Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends
Volume: 22 Issue: 1
Author(s): Aurelio Leone
Affiliation:
Keywords: Smoking, endothelium, atherosclerotic markers.
Abstract: The response to the harm caused by risk factors related to atherosclerosis may consist of clinical-signs of cardiac and/or blood vessel ischemic pathology sometimes accompanied by arrhythmias and heart failure-, metabolic- signs of altered oxygen transport and pro-thrombotic changes of coagulation-fibrinolysis cascade-, and sympathetic features due to nerve stimulation, which cause changes in heart rate and blood pressure. Moreover, some special categories like women have the responses, which are influenced by their endocrine constellation. There is a different predisposition towards the markers of atherosclerosis in premenopausal woman, who displays atherogenic effects, and in women after the menopause who respond similarly to that of men. Finally, oxidative stress, which is a strong pro-thrombotic factor, increases the development of an atherosclerotic lesion.
From these data, there is no doubt that a large number of factors, primarily smoking and endothelial dysfunction influence the cardiovascular system causing a major incidence of cardiovascular events. In addition, there would be evidence that some factors related to atherosclerosis should be considered as an etiologic (causal) factor of cardiovascular alterations because they can lead, in the long run, to an irreversible damage to the heart and blood vessels.
Export Options
About this article
Cite this article as:
Leone Aurelio, Markers of Atherosclerotic Disease: What do they Mean? Current Opinion and Future Trends, Current Pharmaceutical Design 2016; 22 (1) . https://dx.doi.org/10.2174/1381612822666151109111311
DOI https://dx.doi.org/10.2174/1381612822666151109111311 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Role of ABCG2 and ABCB6 in Porphyrin Metabolism and Cell Survival
Current Pharmaceutical Biotechnology Cellular and Molecular Networks in Chronic Myeloid Leukemia: The Leukemic Stem, Progenitor and Stromal Cell Interplay
Current Drug Targets IP6 in Cancer Therapy: Past, Present and Future
Current Cancer Therapy Reviews CXCR3-binding Chemokines: Novel Multifunctional Therapeutic Targets
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Extranuclear Localization of SIRT1 and PGC-1α: An Insight into Possible Roles in Diseases Associated with Mitochondrial Dysfunction
Current Molecular Medicine Selective Modulation of Aβ42 Production in Alzheimers Disease: Non-Steroidal Anti-Inflammatory Drugs and Beyond
Current Pharmaceutical Design Cytokines and Chemokines as Regulators of Angiogenesis in Health and Disease
Current Pharmaceutical Design Interactions Between Apo E and Amyloid Beta and their Relationship to Nutriproteomics and Neurodegeneration
Current Proteomics Phosphodiesterase-5 Inhibitors: Future Perspectives
Current Pharmaceutical Design Editorial [Carotid Intima-Media Thickness and Ezetimibe: The End of a Misunderstanding?]
Current Vascular Pharmacology Ivabradine: A Current Overview
Current Clinical Pharmacology Tracking Stem Cell Therapy in the Myocardium: Applications of Positron Emission Tomography
Current Pharmaceutical Design Pharmacological Therapy of Parkinson’s Disease: Current Options and New Avenues
Recent Patents on CNS Drug Discovery (Discontinued) Editorial: Cocaine and Cerebral Small Vessel: Is it a Negative Factor for Intravenous Thrombolysis?
Current Vascular Pharmacology Cardiac Dys-Synchronization and Arrhythmia in Hyperhomocysteinemia
Current Neurovascular Research Bioactive Compounds of <i>Polygonatum sibiricum</i> - Therapeutic Effect and Biological Activity
Endocrine, Metabolic & Immune Disorders - Drug Targets Actual Knowledge of Systemic Inflammation Reaction During Cardiopulmonary Bypass
Recent Patents on Cardiovascular Drug Discovery Neonatal Hypertension: An Underdiagnosed Condition, A Review Article
Current Hypertension Reviews Aetiology, Diagnosis and Treatment of Hydrops Foetalis
Current Pediatric Reviews Molecular Biological Roles of Ursolic Acid in the Treatment of Human Diseases
Current Bioactive Compounds